Alnylam Pharmaceuticals, Inc. (ALNY)

Last Closing Price: 266.11 (2026-09-04)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Alnylam Pharmaceuticals, Inc. (ALNY) had Net Income of $164.49M for the most recently reported fiscal quarter, ending 2026-06-30.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$1.29B
Net Income
$164.49M
$298.45M
$992.50M
$1.06B
$231.44M
$-53.63M
$177.81M
$177.81M
$164.49M
$164.49M
$164.49M
$164.49M
$231.44M
$245.34M
133.61M
138.28M
$1.23
$1.21
Balance Sheet Financials
$4.62B
$554.14M
$938.60M
$5.56B
$1.51B
$1.01B
$2.69B
$4.20B
$1.35B
$1.35B
$1.35B
133.73M
Cash Flow Statement Financials
$397.23M
$-389.00M
$51.95M
$1.66B
$1.71B
$50.67M
$156.78M
--
--
Fundamental Metrics & Ratios
3.05
--
--
0.43
0.75
76.88%
17.93%
17.93%
--
13.77%
12.74%
$340.71M
--
--
--
0.23
3.07
1.41
63.63
12.15%
12.15%
2.96%
6.96%
$10.13
$2.46
$2.87